Literature DB >> 2394622

Hemangiopericytoma--the role of radiotherapy.

J J Staples1, R A Robinson, B C Wen, D H Hussey.   

Abstract

Between 1955 and 1987, 15 patients with hemangiopericytomas were seen at the University of Iowa Hospitals and Clinics. Twelve of these were thought to have localized tumors and three had metastatic disease at diagnosis. Seven of the 12 patients with localized disease were treated with surgery alone, four were treated with surgery and postoperative radiation therapy, and one was treated with surgery and chemotherapy. Only one of the seven patients initially treated with surgery alone has remained continuously free of disease, although two others were salvaged with radiation therapy. In contrast, all four patients initially treated with surgery and postoperative radiation therapy have remained alive with no evidence of disease in spite of the fact that three of these patients had gross residual tumor at the time of irradiation. Ten patients received radiation therapy at some stage of their management. Local tumor control was achieved at all sites receiving greater than 5500 cGy. Six patients received chemotherapy sometime during the course of their management, although no complete or partial responses were observed. In this small series, mitotic activity was not an accurate predictor of biologic behavior.

Entities:  

Mesh:

Year:  1990        PMID: 2394622     DOI: 10.1016/0360-3016(90)90556-y

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

1.  Hemangiopericytoma of thoracic spine: a rare bony tumor.

Authors:  Raj Kumar; Vivek Kumar Vaid; Vimal Kumar; Samir Kumar Kalra
Journal:  Childs Nerv Syst       Date:  2007-05-31       Impact factor: 1.475

2.  Radiotherapy of bone metastases of a spinal meningeal hemangiopericytoma.

Authors:  K Sakata; Y Aoki; M Tago; K Karasawa; K Nakagawa; K Hasezawa; N Muta; A Terahara; Y Onogi; Y Sasaki; M Hareyama
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

3.  Bone metastasis of intracranial meningeal hemangiopericytoma.

Authors:  Manabu Hoshi; Nobuhito Araki; Norifumi Naka; Masahiko Koizumi; Nobuyuki Hashimoto; Masayuki Onishi; Kenjiro Sugiyasu; Nobuhito Kimura; Shigeki Mori; Kinji Nishiyama; Hideki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

4.  Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study.

Authors:  Connor J Kinslow; Samuel S Bruce; Ali I Rae; Sameer A Sheth; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Adam M Sonabend; Tony J C Wang
Journal:  J Neurooncol       Date:  2018-02-09       Impact factor: 4.130

5.  Metastatic liver cancer: a rare case.

Authors:  Bong-Wan Kim; Hee-Jung Wang; In-Ho Jeong; Sang-Ick Ahn; Myoung-Wook Kim
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

6.  The impact of postoperative radiation therapy on patterns of failure and survival improvement in patients with intracranial hemangiopericytoma.

Authors:  Eun Jung Lee; Jeong Hoon Kim; Eun Suk Park; Shin Kwang Khang; Young Hyun Cho; Seok Ho Hong; Chang Jin Kim
Journal:  J Neurooncol       Date:  2015-12-31       Impact factor: 4.130

7.  [Sinunasal hemangiopericytoma].

Authors:  M Neudert; M Haase; D El-Hifnawi; T Beleites; T Zahnert
Journal:  HNO       Date:  2010-10       Impact factor: 1.284

8.  Concurrent Cochlear Implantation with Resection of Skull Base Hemangiopericytoma following Sudden Deafness in an Only Hearing Ear.

Authors:  Evan R Ransom; Kevin D Judy; Douglas C Bigelow
Journal:  Skull Base       Date:  2010-07

9.  [Hemangiopericytoma (extrapleural solitary fibrous tumour). Exemplified and discussed on the basis of two cases].

Authors:  F Wilde; M Neid; T Schulz; I Sterker; A Hemprich; B Frerich
Journal:  Mund Kiefer Gesichtschir       Date:  2005-11

Review 10.  Meningeal hemangiopericytoma: defining the role for radiation therapy.

Authors:  K T Bastin; M P Mehta
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.